0
Article |

Does Methylprednisolone Pulse Therapy Deteriorate the Course of Rapidly Progressive IgA Nephropathy? FREE

NORITOMO ITAMI, MD; YASUSHI AKUTSU, MD; YUKIHIRO KUSUNOKI, MD; HIROYUKI TOCHIMARU, MD; YASUO TAKEKOSHI, MD
Am J Dis Child. 1989;143(4):441-442. doi:10.1001/archpedi.1989.02150160063007.
Text Size: A A A
Published online

Sir.—We read with interest the article by Welch et al1 in the July 1988 issue of AJDC. They reported that methylprednisolone pulse therapy (MPT) given to three of five children who had rapidly progressive IgA nephropathy did not alter the course of disease in any of the patients. We report that MPT caused deteriorated renal function in a boy with IgA nephropathy. Careful consideration should be given to the use of MPT in children with IgA nephropathy.

Patient Report.—A 12-year-old boy, previously in good health and with no family history of renal disorders, was admitted to our hospital for investigation of microscopic hematuria, proteinuria, and deteriorated renal function. Urinary abnormalities had been detected at a school screening in 1986. At that time, his serum creatinine and blood urea nitrogen levels were within the normal range. Urinary abnormalities had been again detected in 1987, and he had remained

REFERENCES

Welch TR, McAdams J, Berry A:  Rapidly progressive IgA nephropathy . AJDC 1988;;142: 789-793.
Rose BD, Jacobs JB:  Nephrotic syndrome and glomerulonephritis , in Rose BD (ed): Pathophysiology of Renal Disease , ed 2. New York, McGraw-Hill International Book Co, 1987;, pp 179-296.
Couser WG:  Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy . Am J Kidney Dis 1988;;11: 449-464.
Cole BR, Brocklebank JT, Kienstra RA, et al:  'Pulse' methylprednisolone therapy in the treatment of severe glomerulonephritis . J Pediatr 1976;;88:307-314.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Welch TR, McAdams J, Berry A:  Rapidly progressive IgA nephropathy . AJDC 1988;;142: 789-793.
Rose BD, Jacobs JB:  Nephrotic syndrome and glomerulonephritis , in Rose BD (ed): Pathophysiology of Renal Disease , ed 2. New York, McGraw-Hill International Book Co, 1987;, pp 179-296.
Couser WG:  Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy . Am J Kidney Dis 1988;;11: 449-464.
Cole BR, Brocklebank JT, Kienstra RA, et al:  'Pulse' methylprednisolone therapy in the treatment of severe glomerulonephritis . J Pediatr 1976;;88:307-314.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.